Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Critical Reviews in Oncology/Hematology|January 22, 2019
Clinical implications of measurable residual disease in AML: Review of current evidenceIne Moors, Karl Vandepoele, Jan Philippé, et al.International Journal of Laboratory Hematology|June 6, 2024
Variant-specific BCR::ABL1 quantification discrepancy in chronic myeloid leukemiaKoen Jacobs, Alena Moerman, Karl Vandepoele, et al.Acta Tropica|July 28, 2016
The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South KivuJustin C Cikomola, Karl Vandepoele, Philippe B Katchunga, et al.Pediatric Blood & Cancer|October 24, 2018
Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencingCharlotte Derpoorter, Karl Vandepoele, Araceli Diez-Fraile, et al.Plos One|May 22, 2008
A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genesKarl Vandepoele, Vanessa Andries, Nadine Van Roy, et al.BMC Cancer|May 11, 2015
NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrestVanessa Andries, Karl Vandepoele, Katrien Staes, et al.Metallomics : Integrated Biometal Science|July 25, 2017
Whole blood Fe isotopic signature in a sub-Saharan African populationJustin C Cikomola, María R Flórez, Marta Costas-Rodríguez, et al.Clinical Chemistry and Laboratory Medicine|July 10, 2016
A simple colorimetric assay for measuring fructosamine 3 kinase activityJustin C Cikomola, Antoine S Kishabongo, Karl Vandepoele, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|July 26, 2015
Protocadherin-1 binds to SMAD3 and suppresses TGF-β1-induced gene transcriptionGrissel Faura Tellez, Karl Vandepoele, Uilke Brouwer, et al.Cancers|January 1, 2020
Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert PanelGuy Froyen, Marie Le Mercier, Els Lierman, et al.Pageof 3